Agilent Technologies (NYSE:A) posted its quarterly earnings data on Wednesday. The medical research company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.58 by $0.08, Bloomberg Earnings reports. The firm had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.16 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. During the same quarter in the previous year, the business posted $0.53 EPS. Agilent Technologies updated its Q2 guidance to $0.61-0.63 EPS and its FY18 guidance to $2.62-2.68 EPS.
Agilent Technologies (NYSE:A) traded up $2.77 during trading hours on Thursday, reaching $72.47. 1,998,203 shares of the company’s stock traded hands, compared to its average volume of 2,196,965. The stock has a market cap of $22,054.50, a P/E ratio of 34.20, a PEG ratio of 2.06 and a beta of 1.28. Agilent Technologies has a 12 month low of $50.56 and a 12 month high of $75.00. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30.
In other news, CEO Michael R. Mcmullen sold 22,481 shares of the company’s stock in a transaction on Monday, November 20th. The shares were sold at an average price of $70.00, for a total value of $1,573,670.00. Following the sale, the chief executive officer now directly owns 327,882 shares of the company’s stock, valued at approximately $22,951,740. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Michael R. Mcmullen sold 21,850 shares of the company’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the completion of the sale, the chief executive officer now directly owns 324,687 shares in the company, valued at $24,351,525. The disclosure for this sale can be found here. In the last three months, insiders have sold 219,991 shares of company stock worth $15,468,795.
Several research analysts recently commented on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Agilent Technologies from $75.00 to $80.00 and gave the stock an “overweight” rating in a research note on Thursday. Robert W. Baird reiterated a “buy” rating and set a $76.00 price objective on shares of Agilent Technologies in a research note on Thursday, January 18th. Barclays reiterated a “buy” rating and set a $74.00 price objective on shares of Agilent Technologies in a research note on Monday, January 8th. Evercore ISI assumed coverage on shares of Agilent Technologies in a research note on Wednesday, January 3rd. They set an “outperform” rating and a $75.00 price objective for the company. Finally, ValuEngine lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Six equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $69.58.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/15/agilent-technologies-a-releases-quarterly-earnings-results-beats-expectations-by-0-08-eps.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.